125 related articles for article (PubMed ID: 17074676)
1. Papillary serous carcinoma of peritoneum: presentation of 2 cases.
Ruiz-Tovar J; Pérez de Oteyza J; Rojo R; Collado MV; García Villanueva A
Clin Transl Oncol; 2006 Oct; 8(10):758-60. PubMed ID: 17074676
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?
Ayhan A; Taskiran C; Yigit-Celik N; Bozdag G; Gultekin M; Usubutun A; Guler N; Yuce K
Int J Gynecol Cancer; 2006; 16(2):484-9. PubMed ID: 16681715
[TBL] [Abstract][Full Text] [Related]
3. [A case of peritoneal serous papillary carcinoma].
Takeuchi N; Sakata Y; Nishida Y; Nomura Y; Makino T; Maeda T; Tada H; Kimoto T; Ueno S; Fujiwara K
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1337-40. PubMed ID: 21829076
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
[TBL] [Abstract][Full Text] [Related]
5. Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan.
Chao KC; Chen YJ; Juang CM; Lau HY; Wen KC; Sung PL; Fang FY; Twu NF; Yen MS
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):81-4. PubMed ID: 23548224
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
8. Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum.
Kennedy AW; Markman M; Webster KD; Kulp B; Peterson G; Rybicki LA; Belinson JL
Gynecol Oncol; 1998 Nov; 71(2):288-90. PubMed ID: 9826473
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacotherapy in ovarian carcinoma].
Pfisterer J; Du Bois A
MMW Fortschr Med; 2005 Oct; 147(43):34-6. PubMed ID: 16302419
[TBL] [Abstract][Full Text] [Related]
10. [Primary, papillary serous carcinoma of the peritoneum; a report of experiences].
Petru E; Heydarfadai M; Pickel H; Lahousen M; Tamussino K
Geburtshilfe Frauenheilkd; 1992 Sep; 52(9):533-5. PubMed ID: 1397954
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival of a patient with primary papillary serous carcinoma of the peritoneum treated by subtotal peritonectomy plus intraoperative chemohyperthermia.
Ajisaka H; Yonemura Y; Bando E; Fushida S; Nishimura G; Miwa K
Hepatogastroenterology; 2002; 49(46):1027-9. PubMed ID: 12143193
[TBL] [Abstract][Full Text] [Related]
12. Weekly topotecan in a heavily pretreated patient with peritoneal papillary serous adenocarcinoma.
Evans J
Int J Gynecol Cancer; 2004; 14(3):540-2. PubMed ID: 15228430
[TBL] [Abstract][Full Text] [Related]
13. [Experiences with primary, papillary serous peritoneal cancer].
Petru E; Pickel H; Lahousen M; Heydarfadai M
Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():121-2. PubMed ID: 1286312
[No Abstract] [Full Text] [Related]
14. Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy.
Ransom DT; Patel SR; Keeney GL; Malkasian GD; Edmonson JH
Cancer; 1990 Sep; 66(6):1091-4. PubMed ID: 2400962
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal papillary serous carcinoma with long-term survival.
Chen KT; Flam MS
Cancer; 1986 Sep; 58(6):1371-3. PubMed ID: 3742460
[TBL] [Abstract][Full Text] [Related]
16. Remission with carboplatin of paclitaxel resistant primary peritoneal papillary serous carcinoma: case report.
Herrada J; Kudelka AP; Tornos C; Shin DM; Kavanagh JJ; Edwards CL; Verschraegen CF
Eur J Gynaecol Oncol; 1997; 18(1):39-41. PubMed ID: 9061321
[TBL] [Abstract][Full Text] [Related]
17. Primary peritoneal serous papillary carcinoma: a case series.
Blontzos N; Vafias E; Vorgias G; Kalinoglou N; Iavazzo C
Arch Gynecol Obstet; 2019 Oct; 300(4):1023-1028. PubMed ID: 31486887
[TBL] [Abstract][Full Text] [Related]
18. Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: a feasibility study.
Nagao S; Iwasa N; Kurosaki A; Nishikawa T; Ohishi R; Hasegawa K; Goto T; Fujiwara K
Int J Gynecol Cancer; 2012 Jan; 22(1):70-5. PubMed ID: 22146766
[TBL] [Abstract][Full Text] [Related]
19. Primary papillary serous carcinoma of the peritoneum: a case of complete remission of bulky peritoneal disease after chemotherapy.
Saleh WA; Van de Ven CJ; Kim W
Henry Ford Hosp Med J; 1992; 40(1-2):136-8. PubMed ID: 1428967
[TBL] [Abstract][Full Text] [Related]
20. [Peritoneal papillary serous carcinoma: clinical report].
Stagnitti F; Mongardini M; Schillaci F; Scirocchi R; De Petris L; Malizia A; Marenga G; Patrizi V; Priore FM; Corona F; Tiberi R; Di Placido M; Calderisi MD; Longo F
G Chir; 2002 Oct; 23(10):379-82. PubMed ID: 12611260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
